Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gut

• Publication date

  2004-06-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.2003.018911PMID 15194644PMCID PMC1774093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-2-induced reversible hyperbilirubinemia and cholestasis in a patient with Gilbert's syndrome

  2002cited by this paper
• Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls

  2001cited by this paper
• Rectal Tone and Brain Information Processing in Irritable Bowel Syndrome

  2000cited by this paper
• Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.

  2000cited by this paper
• Functional gastrointestinal disorders.

  1999cited by this paper
• Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

  1999cited by this paper
• Functional bowel disorders and functional abdominal pain

  1999cited by this paper
• In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility.

  1998cited by this paper
• Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome

  1998influential reference
• Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat.

  1998cited by this paper
• Standardization of Barostat Procedures for Testing Smooth Muscle Tone and Sensory Thresholds in the Gastrointestinal Tract

  1997cited by this paper
• Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.

  1997cited by this paper
• The functional gastrointestinal disorders

  1997cited by this paper
• Intestinal transit in anxiety and depression.

  1996cited by this paper
• Effects of the corticotropin‐releasing factor (CRF) on rectal afferent nerves in humans

  1996cited by this paper
• Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

  1996cited by this paper
• Motor activity recorded in the unprepared colon of healthy humans.

  1995cited by this paper
• CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues.

  1995cited by this paper
• Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats.

  1994cited by this paper
• Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.

  1993cited by this paper
• Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor.

  1993cited by this paper
• Cerebral-evoked potential responses following direct vagal and esophageal electrical stimulation in humans.

  1993cited by this paper
• Role of CRF in Stress‐Related Alterations of Gastric and Colonic Motor Function a

  1993cited by this paper
• Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study.

  1993cited by this paper
• CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress.

  1992cited by this paper
• Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons.

  1992cited by this paper
• Physiology and pharmacology of corticotropin-releasing factor.

  1991cited by this paper
• Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor.

  1991cited by this paper
• Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

  1990cited by this paper
• Cerebral electrical potentials evoked by balloon distention of the human esophagus.

  1990cited by this paper
• Cold-restraint stress increases rat fecal pellet output and colonic transit.

  1990cited by this paper
• Postprandial colonic transit and motor activity in chronic constipation.

  1990cited by this paper
• Tolerance for rectosigmoid distention in irritable bowel syndrome.

  1990cited by this paper
• Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man.

  1988cited by this paper
• Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome.

  1987cited by this paper
• Gastrointestinal disorders: Behavioral and physiological basis for treatment

  1985cited by this paper
• The effect of cold-restraint stress on gastric emptying in rats.

  1985cited by this paper
• Irritable bowel syndrome : Definition of the syndrome and relation to other disorders. Physiological and psychological mechanism

  1985cited by this paper
• A Guide to gastrointestinal motility

  1983cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper

• Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome

  2025cites this paper
• Corticotropin-releasing hormone receptor-1 antagonist attenuates visceral hypersensitivity induced by trinitrobenzene sulfonic acid colitis and maternal separation in rats

  2025cites this paper
• The Gut‐Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention—A Narrative Review

  2025cites this paper
• Rome Foundation Working Team Report on overlap in disorders of gut–brain interaction

  2025cites this paper
• The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome

  2024cites this paper
• Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial

  2024cites this paper
• Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging

  2024cites this paper
• Role of CRH in colitis and colitis-associated cancer: a combinative result of central and peripheral effects?

  2024cites this paper
• Visceral hypersensitivity induced by mild traumatic brain injury via the corticotropin‐releasing hormone receptor: An animal model

  2023cites this paper
• The Biology of Stress Intolerance in Patients with Chronic Pain—State of the Art and Future Directions

  2023cites this paper
• Maternal separation and TNBS-induced gut inflammation synergistically alter the sexually differentiated stress response in rats

  2023cites this paper
• The locus coeruleus input to the rostral ventromedial medulla mediates stress-induced colorectal visceral pain

  2023cites this paper
• The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment

  2023cites this paper
• Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive review

  2023cites this paper
• Insights into the Characteristics and Functions of Mast Cells in the Gut

  2023cites this paper
• Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer

  2022cites this paper
• Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome

  2022cites this paper
• Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.

  2022cites this paper
• Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies

  2022cites this paper
• Efficacy of a self-management program using an eHealth system to reduce symptom severity in patients with irritable bowel syndrome simultaneously with changes in gut microbiota: a randomized controlled trial

  2022cites this paper
• Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

  2021cites this paper
• Stress and Nasal Allergy: Corticotropin-Releasing Hormone Stimulates Mast Cell Degranulation and Proliferation in Human Nasal Mucosa

  2021cites this paper
• Dysbiosis of the faecal and biliary microbiotas in biliary tract cancer

  2021cites this paper
• Present and Future Therapeutic Approaches to Barrier Dysfunction

  2021cites this paper
• Neuroanatomy and Mechanisms of Visceral Pain

  2021cites this paper
• Oxytocin Antagonist Induced Visceral Pain and Corticotropin-Releasing Hormone Neuronal Activation in the Central Nucleus of the Amygdala during Colorectal Distention in Mice.

  2021cites this paper
• Voiding and storage symptoms in depression/anxiety.

  2021cites this paper
• Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases

  2021cites this paper
• The role of serotonin and its pathways in gastrointestinal disorders

  2021cites this paper
• Regulatory effect of mild moxibustion on P2X3 receptors in spinal cord, anterior cingulate cortex and thalamic ventral posterolateral nucleus of rats with IBS visceral hyperalgesia

  2021cites this paper
• Median arcuate ligament syndrome - Current state of management.

  2021cites this paper
• Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.

  2021cites this paper
• Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut.

  2020cites this paper
• Potential neuro-immune therapeutic targets in irritable bowel syndrome

  2020cites this paper
• Verdauung neu lernen

  2020cites this paper
• Anxiety Disorder Due to a General Medical Condition

  2020cites this paper
• Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

  2020cites this paper
• Electroacupuncture Regulates Disorders of Gut-Brain Interaction by Decreasing Corticotropin-Releasing Factor in a Rat Model of IBS

  2019cites this paper
• Corticotropin‐releasing factor induces inflammatory cytokines via the NLRP6‐inflammatory cytokine axis in a murine model of irritable bowel syndrome

  2019cites this paper
• Cortisol affects pain sensitivity and pain-related emotional learning in experimental visceral but not somatic pain: a randomized controlled study in healthy men and women.

  2019cites this paper
• Title Maladjustment to Academic Life and Employment Anxiety in UniversityStudents with Irritable Bowel Syndrome

  2019cites this paper
• Pathophysiology of the irritable bowel syndrome - Reflections of today.

  2019cites this paper
• Second Asian Consensus on Irritable Bowel Syndrome

  2019cites this paper
• Preoperative anxiety-induced glucocorticoid signaling reduces GABAergic markers in spinal cord and promotes postoperative hyperalgesia by affecting neuronal PAS domain protein 4

  2019cites this paper
• Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms

  2018cites this paper
• Neuro-gastroenterology: Central and Autonomic Nervous System

  2018cites this paper
• Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

  2018cites this paper
• Relationship between job stress and functional dyspepsia in display manufacturing sector workers: a cross-sectional study

  2018cites this paper
• Effect of attention bias modification on event‐related potentials in patients with irritable bowel syndrome: A preliminary brain function and psycho‐behavioral study

  2018cites this paper
• Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls

  2018cites this paper
• The gut microbiota as a key regulator of visceral pain.

  2017cites this paper
• Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin

  2017cites this paper
• Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome

  2017cites this paper
• Intravenous Corticotropin-releasing Hormone Administration Increases Esophageal Electrical Sensitivity in Healthy Individuals

  2017influential citation
• Selective corticotropin-releasing factor 1 receptor antagonist E2508 reduces restraint stress-induced defecation and visceral pain in rat models.

  2017cites this paper
• The effect of intravenous corticotropin-releasing hormone administration on esophageal sensitivity and motility in health.

  2017cites this paper
• Sustained effects of acupuncture in treatment of chronic constipation.

  2017cites this paper
• Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome

  2017cites this paper
• Effect of attention bias modification on brain function and anxiety in patients with irritable bowel syndrome: A preliminary electroencephalogram and psycho‐behavioral study

  2017cites this paper
• Genetics of irritable bowel syndrome

  2016cites this paper
• Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome

  2016cites this paper
• Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome

  2016cites this paper
• Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.

  2016cites this paper
• Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome

  2016cites this paper
• Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome

  2016cites this paper
• Physiology of Visceral Pain.

  2016cites this paper
• Endogenous CRF in rat large intestine mediates motor and secretory responses to stress

  2016cites this paper
• Stress and the Gastrointestinal System

  2016cites this paper
• Use of rifaximin in gastrointestinal and liver diseases.

  2016cites this paper
• The Pharmacology of Visceral Pain.

  2016cites this paper
• Corticotropin-releasing Factor Changes the Phenotype and Function of Dendritic Cells in Mouse Mesenteric Lymph Nodes

  2015cites this paper
• Maladjustment to Academic Life and Employment Anxiety in University Students with Irritable Bowel Syndrome

  2015cites this paper
• Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome

  2015cites this paper
• The Brain–Gut Axis

  2015cites this paper
• Neonatal maternal separation in mice as a pre-clinical model for female chronic pelvic pain

  2015cites this paper
• Die neuronale Mediation von Stress am Beispiel tierexperimenteller Modelle

  2015cites this paper
• Acupuncture and regulation of gastrointestinal function.

  2015cites this paper
• The relationship among psychological and psychophysiological characteristics of fibromyalgia patients.

  2015cites this paper
• Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity.

  2015cites this paper
• Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia.

  2015cites this paper
• Efficacy and Safety of PPC‐5650 on Experimental Rectal Pain in Patients with Irritable Bowel Syndrome

  2015cites this paper
• Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial

  2015cites this paper
• Visceral Pain and Psychiatric Disorders.

  2015cites this paper
• Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia

  2015cites this paper
• Irritable bowel syndrome may be induced by decreased neuroplasticity.

  2014cites this paper
• Irritable bowel syndrome: emerging paradigm in pathophysiology.

  2014cites this paper
• Brain and Gut Interactions in Irritable Bowel Syndrome: New Paradigms and New Understandings

  2014cites this paper
• El mastocito: célula clave en la microinflamación intestinal y en la regulación de la función barrera mediada por el estrés en el síndrome del intestino irritable con predominio de diarrea

  2014cites this paper
• When and How Should We Study Colonic Motility

  2014cites this paper
• Gut-Microbiota and Mental Health : Current and Future Perspectives

  2014cites this paper
• Effectiveness of probiotic Bifidobacterium animalis DN-173010 in the management of constipation-predominant irritable bowel syndrome in black South African women

  2014cites this paper
• Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms

  2014cites this paper
• Stress-induced hyperalgesia.

  2014cites this paper
• Psychological Stress in Chronic Intestinal Diseases

  2014cites this paper
• Neurobiology of stress-induced hyperalgesia.

  2014cites this paper
• Proteinase‐activated receptor 2 modulates corticotropin releasing hormone‐induced brain‐derived neurotrophic factor release from microglial cells

  2014influential citation
• Stress-Induced Pain: A Target for the Development of Novel Therapeutics

  2014cites this paper
• Evidence-based clinical practice guidelines for irritable bowel syndrome

  2014cites this paper
• The Brain-Gut Axis: From Pathophysiology to Possible Future Strategies of

  2014cites this paper
• Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

  2014cites this paper